Total Payments
$10,112
2024 Payments
$2,609
Companies
28
Transactions
505
Medicare Patients
943
Medicare Billing
$56,941
Payment Breakdown by Category
Food & Beverage$9,832 (97.2%)
Education$280.24 (2.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,832 | 501 | 97.2% |
| Education | $280.24 | 4 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $1,397 | 94 | $0 (2024) |
| ABBVIE INC. | $1,364 | 76 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $755.40 | 46 | $0 (2024) |
| Lilly USA, LLC | $645.90 | 31 | $0 (2024) |
| Galderma Laboratories, L.P. | $619.86 | 19 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $481.05 | 19 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $467.23 | 19 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $446.94 | 17 | $0 (2024) |
| Incyte Corporation | $370.91 | 8 | $0 (2024) |
| UCB, Inc. | $369.24 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,609 | 137 | ABBVIE INC. ($396.33) |
| 2023 | $3,012 | 159 | ABBVIE INC. ($546.35) |
| 2022 | $2,703 | 166 | Janssen Biotech, Inc. ($484.64) |
| 2021 | $1,788 | 43 | Galderma Laboratories, L.P. ($349.73) |
All Payment Transactions
505 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: Inflammation | ||||||
| 12/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $5.51 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.07 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: Immunology | ||||||
| 12/12/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Inflammation & Immunology | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $7.86 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $22.79 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.34 | General |
| Category: Immunology | ||||||
| 11/23/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.95 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $7.98 | General |
| Category: DERMATOLOGY | ||||||
| 11/18/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Immunology | ||||||
| 11/14/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $5.17 | General |
| Category: DERMATOLOGY | ||||||
| 11/08/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: DERMATOLOGY | ||||||
| 11/07/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: DERMATOLOGY | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: Immunology | ||||||
| 11/01/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: DERMATOLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.63 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 577 | 1,006 | $125,967 | $34,359 |
| 2022 | 11 | 366 | 586 | $92,894 | $22,582 |
Total Patients
943
Total Services
1,592
Medicare Billing
$56,941
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 85 | $21,199 | $6,387 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 92 | 122 | $21,566 | $6,172 | 28.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 71 | 95 | $21,150 | $5,772 | 27.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 69 | 80 | $15,936 | $3,841 | 24.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 81 | 97 | $12,797 | $2,557 | 20.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $8,420 | $2,432 | 28.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 20 | 23 | $7,581 | $2,169 | 28.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $5,690 | $1,497 | 26.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 63 | 349 | $4,587 | $1,398 | 30.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 33 | 40 | $4,413 | $1,252 | 28.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 17 | 26 | $2,551 | $851.47 | 33.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 14 | 37 | $78.44 | $29.77 | 38.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 69 | $13,604 | $3,632 | 26.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 46 | 50 | $14,068 | $3,287 | 23.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 39 | $11,013 | $3,037 | 27.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 44 | 45 | $11,102 | $2,623 | 23.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 41 | 41 | $10,383 | $2,481 | 23.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 20 | 25 | $9,744 | $2,438 | 25.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $7,217 | $1,796 | 24.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 46 | 53 | $8,404 | $1,434 | 17.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 34 | 212 | $3,326 | $841.27 | 25.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 17 | 21 | $2,701 | $709.21 | 26.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $1,331 | $304.17 | 22.9% |
About Natalie Gibson
Natalie Gibson is a Physician Assistant healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/10/2019. The National Provider Identifier (NPI) number assigned to this provider is 1497390793.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Natalie Gibson has received a total of $10,112 in payments from pharmaceutical and medical device companies, with $2,609 received in 2024. These payments were reported across 505 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($9,832).
As a Medicare-enrolled provider, Gibson has provided services to 943 Medicare beneficiaries, totaling 1,592 services with total Medicare billing of $56,941. Data is available for 2 years (2022–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Austin, TX
- Active Since 11/10/2019
- Last Updated 11/10/2021
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1497390793
Products in Payments
- TREMFYA (Drug) $1,624
- DUPIXENT (Biological) $716.50
- RINVOQ (Biological) $710.09
- TALTZ (Drug) $645.90
- COSENTYX (Drug) $499.89
- OPZELURA (Drug) $370.91
- Sotyktu (Drug) $286.99
- Otezla (Drug) $277.72
- ADBRY (Biological) $264.44
- COSENTYX (Biological) $232.45
- VTAMA (Drug) $218.71
- ILUMYA (Biological) $211.69
- AKLIEF (Drug) $199.00
- Winlevi (Drug) $196.31
- Bimzelx (Biological) $184.84
- SKYRIZI (Biological) $184.01
- EUCRISA (Drug) $182.67
- CLODERM (Drug) $149.13
- BOTOX (Biological) $140.83
- ORACEA (Drug) $136.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Austin
Ms. Selina Santos, Pa-C, PA-C
Physician Assistant — Payments: $465,204
Physician Assistant $465,204
Mr. Stephen Ingram, Pa, PA
Physician Assistant — Payments: $151,100
Physician Assistant $151,100
Mrs. Ashlea Lucas, Pa-C, PA-C
Physician Assistant — Payments: $21,745
Physician Assistant $21,745
Rachel Miller, Pac, PAC
Physician Assistant — Payments: $15,264
Physician Assistant $15,264
Mrs. Alexis Holder, Pa, PA
Physician Assistant — Payments: $14,510
Physician Assistant $14,510
Samantha Eshelman
Physician Assistant — Payments: $14,505
Physician Assistant $14,505